Cancer Cell Metabolism Gene Database

  Cancer Cell Metabolism Gene DB

Home

Search

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Phenotypic Information (metabolism pathway, cancer, disease, phenome)

Mutations: SVs, CNVs, SNVs

Gene expression: GE, Protein, DEGE, CNV vs GE

Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG

Pharmacological Information: Drug-Gene Network

Cross referenced IDs

Gene Summary for SLC25A21
Basic gene info.Gene symbolSLC25A21
Gene namesolute carrier family 25 (mitochondrial oxoadipate carrier), member 21
SynonymsODC|ODC1
CytomapUCSC genome browser: 14q11.2
Genomic locationchr14 :37147125-37641865
Type of geneprotein-coding
RefGenesNM_001171170.1,
NM_030631.3,
Ensembl idENSG00000183032
Descriptionmitochondrial 2-oxodicarboxylate carrieroxodicarboxylate carriersolute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21solute carrier family 25 member 21
Modification date20141207
dbXrefs MIM : 607571
HGNC : HGNC
HPRD : 12124
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_SLC25A21
BioGPS: 89874
Gene Expression Atlas: ENSG00000183032
The Human Protein Atlas: ENSG00000183032
PathwayNCI Pathway Interaction Database: SLC25A21
KEGG: SLC25A21
REACTOME: SLC25A21
ConsensusPathDB
Pathway Commons: SLC25A21
MetabolismMetaCyc: SLC25A21
HUMANCyc: SLC25A21
RegulationEnsembl's Regulation: ENSG00000183032
miRBase: chr14 :37,147,125-37,641,865
TargetScan: NM_001171170
cisRED: ENSG00000183032
ContextiHOP: SLC25A21
cancer metabolism search in PubMed: SLC25A21
UCL Cancer Institute: SLC25A21
Assigned class in ccmGDBC

Top
Phenotypic Information for SLC25A21(metabolism pathway, cancer, disease, phenome)
check002.gifCancer Description
Cancer CGAP: SLC25A21
Familial Cancer Database: SLC25A21
* This gene is included in those cancer gene databases.

.

Oncogene 1

Tumor Suppressor gene 2

Cancer Gene Census 3

CancerGenes 4

Network of Cancer Gene 5

Significant driver gene in

Therapeutic Vulnerabilities in Cancer1

cf) number; DB name
1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long,
2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/,
3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html,
4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long,
5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php,
1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/

check002.gifMetabolic Pathway Description
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES

check002.gifOthers
OMIM
Orphanet
DiseaseKEGG Disease: SLC25A21
MedGen: SLC25A21 (Human Medical Genetics with Condition)
ClinVar: SLC25A21
PhenotypeMGI: SLC25A21 (International Mouse Phenotyping Consortium)
PhenomicDB: SLC25A21

Mutations for SLC25A21
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site.

check002.gifStructural Variants in COSMIC: go to COSMIC mutation histogram

- Statistics for Tissue and Mutation typeTop
- For Inter-chromosomal Variations
There's no inter-chromosomal structural variation.
- For Intra-chromosomal Variations
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'.
SampleSymbol_aChr_aStart_aEnd_aSymbol_bChr_bStart_bEnd_b
large_intestineSLC25A21chr143761074137610741MIPOL1chr143771413637714136
liverSLC25A21chr143744621637446216SLC25A21chr143745402437454024
ovarySLC25A21chr143730358537303605SLC25A21chr143730363537303655
ovarySLC25A21chr143730564637305666SLC25A21chr143730609837306118
ovarySLC25A21chr143752848037528500chr143710179437101814
ovarySLC25A21chr143760849437608514SLC25A21chr143762418537624205
pancreasSLC25A21chr143715855037158570BRMS1Lchr143632953336329553
pancreasSLC25A21chr143737287237372892chr144047173840471758
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract)

check002.gifRelated fusion transcripts : go to Chitars2.0
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows SLC25A21 related fusion information.
IDHead GeneTail Gene
AccessionGene_aqStart_aqEnd_aChromosome_atStart_atEnd_aGene_aqStart_aqEnd_aChromosome_atStart_atEnd_a

check002.gifOther DBs for Structural Variants
Structural Variants in Ensembl: go to Ensembl Structural variation
Structural Variants in dbVar: go to dbVar

Top
check002.gifCopy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr
 
Mutation type/ Tissue IDbrcacnscervendomehaematopokidnLintestliverlungnsovarypancreprostskinstomathyrourina
Total # sample81   22 26 2 311 3
GAIN (# sample)7    2  26 2 311 2
LOSS (# sample)11    2         1
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract)

Top
check002.gifSNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation

 : Non-synonymous mutation, : Synonymous mutation, Circle size denotes number of samples.
Maximum mutation count=4

Top
check002.gifSomatic Mutation Counts per Tissue in COSMIC data
Stat. for Non-Synonymous SNVs
(# total SNVs=20)
Stat. for Synonymous SNVs
(# total SNVs=3)
Stat. for Deletions
(# total SNVs=2)
Stat. for Insertions
(# total SNVs=0)
There's no inserted snv.

Top
check002.gifTop 10 SNVs Having the Most Samples in COSMIC data
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID.
GRCh37 positionMutation(aa)Unique sampleID count
chr14:37154057-37154057p.I226T3
chr14:37180638-37180638p.W163*2
chr14:37194791-37194791p.R141Q2
chr14:37194792-37194792p.R141W2
chr14:37153057-37153057p.P272S2
chr14:37203772-37203772p.F70fs*202
chr14:37283130-37283130p.M66L2
chr14:37194883-37194883p.?1
chr14:37344201-37344201p.E27K1
chr14:37180645-37180645p.E161*1

Top
check002.gifSNV Counts per Each Loci in TCGA data

 : non-synonymous mutation, : synonymous mutation, Circle size denotes number of samples.
maximum mutation count=2

Point Mutation/ Tissue ID1234567891011121314151617181920
# sample 113  2    21   74 3
# mutation 113  2    21   75 2
nonsynonymous SNV 112  2    1    74 2
synonymous SNV   1       11    1  
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma])

Top
check002.gifTop 10 SNVs Having the Most Samples in TCGA data
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID.
Genomic PositionMutation(aa)Unique sampleID count
chr14:37283178p.R141W,SLC25A212
chr14:37194792p.P272S,SLC25A212
chr14:37153057p.P50S,SLC25A212
chr14:37283144p.G152G,SLC25A211
chr14:37180580p.A113V,SLC25A211
chr14:37180664p.A113T,SLC25A211
chr14:37344171p.G102E,SLC25A211
chr14:37180670p.T84I,SLC25A211
chr14:37641501p.R276R,SLC25A211
chr14:37153043p.I76V,SLC25A211

check002.gifOther DBs for Point Mutations
Point Mutation Table of Ensembl: go to Ensembl variation table
Mutation of cBioPortal: go to cBioPortal's Cross-cancer alteration summary

check002.gifCopy Number for SLC25A21 in TCGA
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene.
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma]

Top
Gene Expression for SLC25A21

check002.gifGene Expression in Cancer Cell-lines (CCLE)
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data.

check002.gifDifferential Gene Expression in Primary Tumors (TCGA)
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis.
(t test, adjusted p<0.05 (using Benjamini-Hochberg FDR))
Top
check002.gifCNV vs Gene Expression Plot
* This plots show the correlation between CNV and gene expression.

: Open all plots for all cancer types


Top
Gene-Gene Network Information
check002.gifCo-Expressed gene's network Plot
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown.
Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene

: Open all plots for all cancer types

ANKS4B,BAZ1A,LINC01559,PCNXL4,CHD8,CTAGE5,DTWD2,
FANCM,LINC01184,GRIN2B,KIAA0391,MIPOL1,PAX9,POLE2,
RALGAPA1,RDH11,REG4,SLC25A21,TRAPPC6B,TTLL5,ZNF253
ARMC1,NADK2,DCTN4,FAM120C,FAM47E,FBXO9,FRS2,
MBTPS2,NRIP1,NT5DC1,PLA2G12A,RAB18,RAD21,TRMT10A,
RHOT1,RNF170,SENP2,ARHGEF26,SLC25A21,SRPK2,UBE2W

ANXA13,CA8,CIB4,CIT,CKAP4,FAM174B,GALNT8,
KIF19,MAK,MIPOL1,OPRD1,PCSK1,RAP1GAP,RHBDL3,
SLAIN1,SLC25A21,SLC26A9,SPINK4,SSTR1,STXBP1,UGT2B4
ARL4D,C16orf45,CAB39L,CES1,CFL2,FBXO17,MORN5,
MSRB3,MXRA7,NT5DC3,NUDT10,NUDT11,PDLIM3,PDLIM4,
PTPLA,RASL12,RASSF8,SLC25A21,SOX15,ST3GAL3,TSPAN2
check002.gifCo-Expressed gene's Protein-protein interaction Network Plot
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown.
Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene

: Open all plots for all cancer types

Top
check002.gifInteracting Genes (from Pathway Commons)

: Open all interacting genes' information including KEGG pathway for all interacting genes from DAVID

Top
Pharmacological Information for SLC25A21
check002.gifCross-referenced pharmacological DB IDs from Uniprot
DB CategoryDB NameDB's ID and Url link

check002.gifDrug-Gene Interaction Network
* Gene Centered Interaction Network.
* Drug Centered Interaction Network.
DrugBank IDTarget NameDrug GroupsGeneric NameDrug Centered NetworkDrug Structure
DB00123solute carrier family 25 (mitochondrial oxoadipate carrier), member 21approved; nutraceuticalL-Lysine


Top
Cross referenced IDs for SLC25A21
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section

: Open all cross reference information



Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @
Site Policies | State of Texas